Scientists test brain chemical to unlock migraine mystery
NCT ID NCT07451769
Summary
This study aims to understand if a natural brain chemical called adrenomedullin can trigger migraine attacks. Researchers will give participants a migraine prevention drug (erenumab) first to block one pathway, then give adrenomedullin to see if it still causes a migraine. The goal is to learn more about how migraines start, not to treat them.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Danish Headache Center
Glostrup Municipality, 2600, Denmark
Conditions
Explore the condition pages connected to this study.